BRIEF published on 11/07/2024 at 07:05, 9 months 12 days ago Swiss Re Bolsters US Liability Reserves Amidst Comprehensive Review Financial Targets Swiss Re 2024 Results US Liability Reserves P&C Re
BRIEF published on 11/07/2024 at 07:05, 9 months 12 days ago Swiss Re renforce ses réserves de responsabilité civile aux États-Unis dans le cadre d'un examen complet Objectifs Financiers Swiss Re Résultats 2024 Réserves De Passif Des États-Unis Assurance P&C
PRESS RELEASE published on 11/07/2024 at 07:00, 9 months 12 days ago Swiss Re strengthens US liability reserves, following a comprehensive reserve review Swiss Re strengthens US liability reserves by USD 2.4 billion in Q3 2024, positioning overall reserves at the higher end of the best-estimate range Financial Results Swiss Re US Liability Reserves P&C Re Reserve Review
BRIEF published on 11/05/2024 at 09:05, 9 months 14 days ago Swiss Re to Divest iptiQ's European P&C Business to Allianz Direct Swiss Re Divestment IptiQ Sale Allianz Direct Acquisition European P&C Market B2B2C Insurance
BRIEF published on 11/05/2024 at 09:05, 9 months 14 days ago Swiss Re cède l'activité IARD européenne d'iptiQ à Allianz Direct Désinvestissement De Swiss Re Vente IptiQ Acquisition Directe D'Allianz Marché Européen De L'assurance IARD Assurance B2B2C
PRESS RELEASE published on 11/05/2024 at 09:00, 9 months 14 days ago Swiss Re agrees to sell iptiQ's European P&C business to Allianz Direct Swiss Re to sell iptiQ's European P&C business to Allianz Direct in strategic move. Transaction includes various European markets and is expected to close in Q2/Q3 2025, pending regulatory approvals Insurance Swiss Re Mergers & Acquisitions European Markets Allianz Direct
BRIEF published on 09/16/2024 at 10:05, 11 months 3 days ago Covid-19 May Lead to Longest Period of Peacetime Excess Mortality, Says New Swiss Re Report COVID-19 Impact Excess Mortality Healthcare Disruption Insurance Risk Medical Advancements
BRIEF published on 09/16/2024 at 10:05, 11 months 3 days ago Le Covid-19 pourrait entraîner la plus longue période de surmortalité en temps de paix, selon un nouveau rapport de Swiss Re Impact Du COVID-19 Surmortalité Perturbation Des Soins De Santé Risque D'assurance Progrès Médicaux
PRESS RELEASE published on 09/16/2024 at 10:00, 11 months 3 days ago Covid-19 may lead to longest period of peacetime excess mortality, says new Swiss Re report Swiss Re report warns of potential long-lasting peacetime excess mortality due to COVID-19 impact. Excess mortality rates may remain up to 3% higher in the US and 2.5% in the UK by 2033 COVID-19 Healthcare Research Swiss Re Excess Mortality
BRIEF published on 09/09/2024 at 07:05, 11 months 10 days ago Swiss Re constate une demande croissante de réassurance dans un environnement volatil Réassurance Catastrophes Naturelles Instabilité Économique Assurance Cybernétique Environnement Contentieux
Published on 08/19/2025 at 15:00, 1 hour 23 minutes ago Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
Published on 08/19/2025 at 14:30, 1 hour 53 minutes ago Sekur Private Data Ltd. Signs Distribution Agreement with Rich TV to Promote Sekur Privacy Solutions
Published on 08/19/2025 at 14:30, 1 hour 53 minutes ago Strategic Metals samples 2740 g/t silver and 8.37 g/t gold at its Triple Crown Project, Yukon
Published on 08/19/2025 at 14:30, 1 hour 53 minutes ago MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Published on 08/19/2025 at 14:00, 2 hours 23 minutes ago bioEnergy Development Announces Bio-Waste Testing Pipeline at Capacity for Q3 2025
Published on 08/19/2025 at 16:11, 12 minutes ago Fuller, Smith & Turner PLC: Block Listing Application
Published on 08/19/2025 at 15:59, 24 minutes ago audius increases total operating performance organically by 17.5% / Second quarter shows significantly positive momentum / Forecast raised
Published on 08/19/2025 at 15:41, 42 minutes ago Delisting of the shares of artnet AG from the Frankfurt Stock Exchange as of August 22, 2025
Published on 08/19/2025 at 15:37, 46 minutes ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
Published on 08/18/2025 at 18:01, 22 hours 22 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA américaine pour l’ajout du prélèvement nasal antérieur avec son test BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
Published on 08/18/2025 at 18:01, 22 hours 22 minutes ago bioMérieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
Published on 08/18/2025 at 17:45, 22 hours 38 minutes ago FREY REINFORCES ITS LEADING POSITION IN PREMIUM OUTLETS BY ACQUIRING THREE MAJOR SITES IN ITALY FOR €410 MILLION
Published on 08/18/2025 at 17:45, 22 hours 38 minutes ago FREY RENFORCE SON LEADERSHIP SUR LES PREMIUM OUTLETS AVEC L’ACQUISITION DE 3 SITES MAJEURS EN ITALIE POUR UN MONTANT DE 410 M€
Published on 08/18/2025 at 17:45, 22 hours 38 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2025 07 31
